Clinical Trial Update: Plasma and Platelet microRNAs in Clopidogrel Low Response Patients [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial is investigating plasma and platelet microRNAs in patients with coronary artery disease who have a low response to clopidogrel. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Clopidogrel (Plavix) (clopidogrel)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN